Original Research
Accepted on 15 Aug 2025
LOW RATE OF INFECTIOUS MORTALITY OMITTING FLUOROQUINOLONE PROPHYLAXIS IN HIGH-RISK HEMATOLOGICAL PATIENTS, A SINGLE CENTER EXPERIENCE
in Antimicrobials, Resistance and Chemotherapy
- 209 views
Original Research
Accepted on 15 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 15 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 14 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 14 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 13 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 12 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 12 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 12 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 12 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 12 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 11 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 11 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 11 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 11 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Correction
Published on 11 Aug 2025
in Antimicrobials, Resistance and Chemotherapy
Editorial
Accepted on 08 Aug 2025
in Antimicrobials, Resistance and Chemotherapy